, Inc. (OTC:BHRT) surged nearly 27% on Monday after the biological developer of cell treatment therapies gained the exclusive rights to use Ageless Regenerative Institute's adipose therapeutic cell technology for cardiac purposes worldwide, according to a company press release. Yesterday, BHRT advanced $0.012, or 26.67%, to $0.057, its highest close since Dec. 14. Shifting in excess of 5.47 million shares, BHRT scored its highest volume since Jul. 21. read more in hotstocked.com
Composite Indicators: Buy Short Term Indicators Average: 100% Buy Medium Term Indicators Average: 50% Buy Long Term Indicators Average: 33% Buy Overall Average: 72% Buy